Company / Interest Expense per Share
Idexx Laboratories Interest Expense per Share History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.50
FY2023
5-year range
$0.35 / $0.50
FY2019-FY2023
Trend
+6.4%
vs FY2022
Sector context
#27 of 40
Health Care
What the data says
At $0.50, Idexx Laboratories's interest expense per share ranks #14 of 40 in the Health Care sector. Interest Expense per Share has fluctuated over the past 8 years, ranging from $0.32 in FY2016 to $0.50 in FY2023.
Based on SEC 10-K filings.
0.50 in FY2023 with a 5-year CAGR of +4.7%.
Increased from $0.35 to $0.50 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +9.0%
- 5-Year CAGR
- +4.7%
- 10-Year CAGR
- -
Sector benchmark
#14 of 40 in Health CareTop 32% of 40This company $0.50 Sector average $1.56
▼
-67.9% below sector average
Key checks
Key Insights
- In FY2023, interest expense per share increased 6.4% year-over-year.
- Ranks #27 out of 40 companies in the Health Care sector.
- Lowest interest expense per share in the period was in FY2016.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 4.60 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 65.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.50 | +6.4% |
| FY2022 | $0.47 | +35.1% |
| FY2021 | $0.35 | -10.0% |
| FY2020 | $0.39 | +7.5% |
| FY2019 | $0.36 | -9.6% |
| FY2018 | $0.40 | +0.3% |
| FY2017 | $0.40 | +25.9% |
| FY2016 | $0.32 | +16.6% |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026